Synthetic Biologics Buy Hold or Sell Recommendation
| SYNDelisted Stock | USD 1.02 0.00 0.00% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding Synthetic Biologics is 'Not Rated'. Macroaxis provides Synthetic Biologics buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding SYN positions. The advice algorithm takes into account all of Synthetic Biologics' available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Synthetic Biologics' buy or sell advice are summarized below:
Real Value 1.01 | Hype Value 1.02 | Market Value 1.02 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Synthetic Biologics given historical horizon and risk tolerance towards Synthetic Biologics. When Macroaxis issues a 'buy' or 'sell' recommendation for Synthetic Biologics, the advice is generated through an automated system that utilizes algorithms and statistical models.
Synthetic |
Execute Synthetic Biologics Buy or Sell Advice
The Synthetic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Synthetic Biologics. Macroaxis does not own or have any residual interests in Synthetic Biologics or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Synthetic Biologics' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Not Rated
Synthetic Biologics Trading Alerts and Improvement Suggestions
| Synthetic Biologics is not yet fully synchronised with the market data | |
| Synthetic Biologics has some characteristics of a very speculative penny stock | |
| Synthetic Biologics has a very high chance of going through financial distress in the upcoming years | |
| Reported Net Loss for the year was (14.27 M) with profit before taxes, overhead, and interest of 0. | |
| Synthetic Biologics has about 67.33 M in cash with (12.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.3, which can makes it an attractive takeover target, given it will continue generating positive cash flow. |
Synthetic Biologics Returns Distribution Density
The distribution of Synthetic Biologics' historical returns is an attempt to chart the uncertainty of Synthetic Biologics' future price movements. The chart of the probability distribution of Synthetic Biologics daily returns describes the distribution of returns around its average expected value. We use Synthetic Biologics price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Synthetic Biologics returns is essential to provide solid investment advice for Synthetic Biologics.
| Mean Return | -1.13 | Value At Risk | -7.02 | Potential Upside | 4.96 | Standard Deviation | 5.08 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Synthetic Biologics historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Synthetic Biologics Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Synthetic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.049 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 1.0 | |||
| Day Typical Price | 1.0 | |||
| Market Facilitation Index | 0.05 | |||
| Price Action Indicator | 0.025 |
About Synthetic Biologics Buy or Sell Advice
When is the right time to buy or sell Synthetic Biologics? Buying financial instruments such as Synthetic Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Synthetic Biologics in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Power Assets Thematic Idea Now
Power Assets
Large capitalization equities showing high long-term performance indicators and above average return expectations based on Macroaxis rating system. The Power Assets theme has 49 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Power Assets Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Synthetic Stock
If you are still planning to invest in Synthetic Biologics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Synthetic Biologics' history and understand the potential risks before investing.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |